Clinical trial
D-Dimer and IPG for Recurrent Thrombosis (DIRECT) Study
NCT00182247 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- D-Dimer and IPG for Recurrent Thrombosis (DIRECT) Study
- Lead sponsor
- Hamilton Health Sciences Corporation
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- December 31, 1998
- Completion date
- January 31, 2001
- Enrollment
- 600
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
deep vein thrombosis, pulmonary embolism